AU3245593A - Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (+) zopiclone - Google Patents
Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (+) zopicloneInfo
- Publication number
- AU3245593A AU3245593A AU32455/93A AU3245593A AU3245593A AU 3245593 A AU3245593 A AU 3245593A AU 32455/93 A AU32455/93 A AU 32455/93A AU 3245593 A AU3245593 A AU 3245593A AU 3245593 A AU3245593 A AU 3245593A
- Authority
- AU
- Australia
- Prior art keywords
- disorders
- zopiclone
- compositions
- methods
- optically pure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80131291A | 1991-12-02 | 1991-12-02 | |
US801312 | 1991-12-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3245593A true AU3245593A (en) | 1993-06-28 |
Family
ID=25180769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU32455/93A Abandoned AU3245593A (en) | 1991-12-02 | 1992-12-01 | Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (+) zopiclone |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3245593A (en) |
WO (1) | WO1993010787A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6339086B1 (en) | 1999-05-14 | 2002-01-15 | Swpracor, Inc. | Methods of making and using N-desmethylzopiclone |
US7465729B2 (en) | 2004-04-05 | 2008-12-16 | Sepracor Inc. | Methods of treatment of menopause and perimenopause using eszopiclone |
US7776858B2 (en) | 2004-04-05 | 2010-08-17 | Sepracor Inc. | Methods of treatment of chronic pain using eszopiclone |
US8268832B2 (en) | 2007-12-19 | 2012-09-18 | Sunovion Pharmaceuticals Inc. | Maleate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
US20110053945A1 (en) * | 2007-12-19 | 2011-03-03 | Sepracor Inc. | Salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihy-dro-5h-pyrrolo[3,4-b]pyrazine |
US8269005B2 (en) | 2007-12-19 | 2012-09-18 | Sunovion Pharmaceuticals Inc. | L-malate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-Oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
US8198278B2 (en) | 2007-12-19 | 2012-06-12 | Sunovion Pharmaceuticals Inc. | Besylate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
US8212036B2 (en) | 2007-12-19 | 2012-07-03 | Sunovion Pharmaceuticals Inc. | Maleate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
US8198277B2 (en) | 2007-12-19 | 2012-06-12 | Sunovion Pharmaceuticals Inc. | L-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
WO2009085972A1 (en) * | 2007-12-19 | 2009-07-09 | Sepracor Inc. | Maleate, besylate, and l-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine |
EP3632417A1 (en) | 2009-01-30 | 2020-04-08 | Sunovion Pharmaceuticals Inc. | Coated tablets of 6-(5-chloro-2-pyridyl) -5-[ (4-methyl-1-piperazinyl) carbonyloxy]-7-oxo-6, 7-dihydro-5h-pyrrolo [3,4-b] pyrazine |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
OA04285A (en) * | 1972-01-07 | 1979-12-31 | Rhone Poulenc Sa | New derivatives of pyrrolo (3,4-b) pyrazine and their preparation. |
-
1992
- 1992-12-01 WO PCT/US1992/010631 patent/WO1993010787A1/en active Application Filing
- 1992-12-01 AU AU32455/93A patent/AU3245593A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1993010787A1 (en) | 1993-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6904498A (en) | Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole | |
AU7039896A (en) | Methods and compositions for treating emesis, nausa and other disorders using optically pure R(+) ondansetron | |
AU2187992A (en) | Composition and method for disease treatment | |
AU2287495A (en) | Methods and compositions for treating depression and other disorders using optically pure s(+) fluoxetine | |
AU7577994A (en) | Methods for inhibiting bone loss | |
AU7540591A (en) | Sludge treatment process | |
EP0647134A4 (en) | Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine. | |
AU3245593A (en) | Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (+) zopiclone | |
EP0708639A4 (en) | Methods and compositions for treating depression and other disorders using optically pure (+) sibutramine | |
AU5652698A (en) | (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors | |
AU5359490A (en) | Eyewear retainer | |
AU7249494A (en) | Method for increasing the capacity of sewage treatment plant | |
EP0700292A4 (en) | Methods and compositions for treating gastric disorders using optically pure (+) pantoprazole | |
AU6993798A (en) | Methods and compositions using optically pure (+)-zileuton | |
AU6993998A (en) | Methods and compositions for treating asthma, atherosclerosis and inflammatory diseases using optically pure (-)-zileuton | |
AU6927894A (en) | 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions | |
AU3275993A (en) | Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (-) zopiclone | |
AU1175692A (en) | Effluent treatment | |
AU2434992A (en) | Methods and compositions for treating sunburns | |
AU1578795A (en) | Enantiomerically pure (+)-liarozole | |
AU3974495A (en) | Optical treatment method | |
AU6904598A (en) | Methods and compositions for treating gastric disorders using optically pure (+) pantoprazole | |
AU1515197A (en) | Methods and compositions for treating infection using optically pure (S)-lomefloxacin | |
AU2003204192A1 (en) | Methods and Compositions for Treating Gastric Disorders Using Optically Pure (-) Pantoprazole | |
AU696392B2 (en) | Methods and compositions for treating depression and other disorders using optically pure (+) sibutramine |